Subsequent dedicated renal outcome trials, namely the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) and Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA CKD) studies, confirmed the effects of canagliflozin and dapagliflozin on primary renal endpoints in advanced CKD patients [10,30]
First in, first out If you have multiple vials or pens, always use the oldest one first
Tirzepatide combines GLP-1 with GIP receptor activation, while Semaglutide focuses solely on GLP-1, available in both oral and injectable forms
When to contact a clinician after stopping semaglutide Reach out to your doctor if you experience more serious symptoms, like: Consistent vomiting Blood sugar spikes and dips Chest pain Increased anxiety or depression Daily habits that help maintain weight loss after semaglutide Minimizing weight regain after GLP-1s starts with holistic lifestyle changes
Enhanced skeletal muscle for effective glucose homeostasis
